Subarachnoid hemorrhage: management considerations for COVID-19

Subarachnoid hemorrhage (SAH) has deleterious outcomes for patients, and during the hospital stay, patients are susceptible to vasospasm and delayed cerebral ischemia. Coronavirus disease 2019 (COVID-19) has been shown to worsen hypertension through angiotensin-converting enzyme 2 (ACE2) activity, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Panther, Eric J., Lucke-Wold, Brandon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951071/
https://www.ncbi.nlm.nih.gov/pubmed/35340712
http://dx.doi.org/10.37349/ent.2022.00018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951071/
https://www.ncbi.nlm.nih.gov/pubmed/35340712
http://dx.doi.org/10.37349/ent.2022.00018

Ejemplares similares